Fig. 8From: Mechanism of Smilax china L. in the treatment of intrauterine adhesions based on network pharmacology, molecular docking and experimental validationVisualization of target and component molecular docking results. (A) HIF-kaemferid (B) VEGFA-beta-sitosterol (C) TP53-taxifolin (D) EGFR-beta-sitosterol (E) BCL2-AST (F) MMP9-diosgenin (G) CASP3-isogenlitin (H) MTOR-beta-sitosterol (I) AKT-diosgenin (J) RELA-beta-sitosterolBack to article page